*Financial News*

Source: Leading Newspapers

*Compiled by Rudra Shares* 

Vande Mataram

*Thursday, 23 July 2026*

*Banking, Finance & Regulation*
• Punjab National Bank eyes entry into world's top 100 banks in the next 2 years.
• Banks to tap 25 OEMs in battle against AI-led cybersecurity threats.
• Foreign banks show strongest rate transmission in current RBI easing cycle: RBI Bulletin.
• Blackstone ties up with HDFC Ergo Ex-MD Anuj Tyagi for new insurance business.
• MSEDCL appoints 8 bankers for ₹10,000 crore IPO.
• Mauritius tax route to come under India taxman's lens.
• Bandhan Bank shares crash as guidance cut spooks Street.
• Carnelian Asset Management receives SEBI approval to launch mutual fund business.
• Flexi cap funds post fastest folio growth; sectoral funds remain the largest equity category.
• FIIs sell shares worth ₹819 crore; DIIs remain net sellers with ₹418 crore outflow on July 22.

*Power, Energy & Infrastructure*
• Delhi HC upholds Centre's decision to deny oil block extension to Vedanta.
• Bajel Projects signs 500 kV transmission line pact with EETC in Cairo.
• JSW Infrastructure eyes 127 MT cargo in FY27 even as Fujairah terminal disruption continues.
• Crude oil crosses $95 as US strikes enter the 12th day.

*Information Technology & Telecom*
• HCLTech likely to build its first India data centre in Odisha's Bhubaneswar.
• MTNL liabilities jump to ₹40,000 crore in FY26, but the company remains EBITDA positive: Jyotiraditya Scindia.

*Automobile*
• TVS Motor sees international business maintaining growth momentum in FY27.

*FMCG & Retail*
• GCPL invests ₹200 crore in subsidiary Godrej Pet Care via rights issue.
• Nestlé extends rally on stellar June quarter; higher costs may limit upside.
• From Reliance to Tata's Trent: Retailers line up ₹4,000 crore for their biggest expansion in years.

*Healthcare & Pharmaceuticals*
• Trump's 200% generic drug tariff threat puts $9.7 billion of Indian pharma exports at risk; industry says reshoring is not practical.
• Pharma stocks slide on Trump's generic drug tariff plan.
• Not practical to shift generic drug manufacturing to the US: Dr Reddy's CEO on Trump's tariff plan.

*Capital Goods & Defence*
• Apollo Micro secures Indian Navy prototype order for autonomous underwater surveillance; shares rise.

*Economy & Trade*
• US–India trade deal could be signed in 3–4 months, says a US official.
• India is winning the battle against hunger, but not food costs.
• Oil at $90–100 will impact macroeconomy and markets: Sunil Koul.

*Capital Markets / IPO*
• Advance Technoforge IPO to open on July 27; aims to raise ₹24 crore.
• Lohia Corp raises ₹492 crore from anchor investors ahead of its ₹1,102 crore IPO.
• Indo-MIM mobilises ₹1,141 crore via anchor book; ₹3,812-crore IPO opens today.

*Politics*
• Couple of punches are not a problem, happy to take many more for people: Rahul Gandhi.
• Pradhan unlikely to resign, but Centre keen on relief measures for victims' families: Government functionary.
• Suvendu warns Mamata is "not above law", says Abhishek will lose Diamond Harbour.
• Chaos in West Bengal Assembly; TMC MLA Kunal Ghosh marshalled out.
• Supreme Court seeks Lok Sabha Speaker's reply on approval for UBT Sena MPs' merger with Shinde Sena.
• NEET paper leak row: J. P. Nadda hits back at Rahul Gandhi, accuses Congress of seeking political mileage.
• Sonam Wangchuk says he will end his fast if the government assures no action against CJP protesters.
• "Dharmendra Pradhan's resignation is non-negotiable": CJP on NEET protest.

 *Commodities* 
• GOld(spot): Rs 144563
• Silver (spot): Rs 225109

*Jai Hind*
*Rudra Hai to Mudra Hai*
For more details:
www.rudrashares.com/cef